Overcoming Cisplatin Resistance in Non-Small Cell Lung Cancer with Mad2 Silencing siRNA Delivered Systemically using EGFR-Targeted Chitosan Nanoparticles.
admin-cespu
Bibliographic reference:
Nascimento AV., Singh A., Bousbaa H., Ferreira D., Sarmento B., & Amiji M. (2017). Overcoming Cisplatin Resistance in Non-Small Cell Lung Cancer with Mad2 Silencing siRNA Delivered Systemically using EGFR-Targeted Chitosan Nanoparticles. Acta Biomaterialia 47:71-80.
Nascimento AV., Singh A., Bousbaa H., Ferreira D., Sarmento B., & Amiji M. (2017). Overcoming Cisplatin Resistance in Non-Small Cell Lung Cancer with Mad2 Silencing siRNA Delivered Systemically using EGFR-Targeted Chitosan Nanoparticles. Acta Biomaterialia 47:71-80.